Hepatic Manifestations of STAT1 Gain-of-Function Variants
The Journal of Allergy and Clinical Immunology: In Practice · 2026
DOI: 10.1016/j.jaip.2026.01.045 ↗Kurz gefasst
Fallbericht in der Zeitschrift The Journal of Allergy and Clinical Immunology: In Practice, 2026. Verfasst von Wesam Aleyadeh und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Hepatology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Hea…. Hauptthemen laut MEDLINE: Gain of Function Mutation, Immune System Diseases, Liver Diseases, STAT1 Transcription Factor. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural NIH HHS.
Abstract (Originalsprache)
Primary immune regulatory disorders (PIRDs) are inborn errors of immunity characterized by immune dysregulation and multisystem involvement, whose hepatic manifestations can mimic autoimmune, cholestatic, or microvascular liver disease. Among these, heterozygous signal transducer and activator of transcription 1 gain-of-function pathogenic variants are predominantly associated with autoimmune hepatitis-like liver injury whereas vascular and portal hypertensive phenotypes are rarely reported and likely underrecognized. We describe a young adult with recurrent infections and progressive liver disease who ultimately received the diagnosis of a signal transducer and activator of transcription 1 gain-of-function mutation. The case illustrates the spectrum of hepato-gastrointestinal involvement in PIRDs, emphasizing diagnostic considerations, imaging and histopathologic features, and management strategies including conventional immunosuppression, targeted Janus kinase inhibition, and hematopoietic stem cell transplantation. We also outline infectious complications of Janus kinase inhibition, including progressive multifocal leukoencephalopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Hepatology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md. Electronic address: wesam.aleyadeh@nih.gov.
- Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Md.
- Translational Hepatology Section, Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Md.
- Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Förderung
- Intramural NIH HHS
Zitieren
APA
Aleyadeh, W., Lin, W., Pirzada, S. A., Fathma, S., Bergerson, J. R. E., Lionakis, M. S., Holland, S. M., Kleiner, D. E., & Heller, T. (2026). Hepatic Manifestations of STAT1 Gain-of-Function Variants. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2026.01.045
Vancouver
Aleyadeh W, Lin W, Pirzada SA, Fathma S, Bergerson JRE, Lionakis MS, et al. Hepatic Manifestations of STAT1 Gain-of-Function Variants. The Journal of Allergy and Clinical Immunology: In Practice. 2026. doi:10.1016/j.jaip.2026.01.045
BibTeX
@article{Aleyadeh2026,
author = {Aleyadeh, Wesam and Lin, Wanrun and Pirzada, Sana A and Fathma, Sawsan and Bergerson, Jenna R E and Lionakis, Michail S and Holland, Steven M and Kleiner, David E and Heller, Theo},
title = {Hepatic Manifestations of STAT1 Gain-of-Function Variants},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
year = {2026},
doi = {10.1016/j.jaip.2026.01.045}
}
EUVIMED